HAEM4:Monomorphic T/NK-cell PTLD - Revision history

Bailey.Glen at 21:43, 4 December 2023

2023-12-04T21:43:26Z

← Older revision		Revision as of 16:43, 4 December 2023
Line 139:		Line 139:
	==Links==		==Links==

	[[Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)]]		[[HAEM4:Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)]]

	[[Post-Transplant Lymphoproliferative Disorders]]		[[HAEM4:Post-Transplant Lymphoproliferative Disorders]]

	[[Immunodeficiency-Associated Lymphoproliferative Disorders]]		[[HAEM4:Immunodeficiency-Associated Lymphoproliferative Disorders]]

	Put your links here (use "Link" icon at top of page)		Put your links here (use "Link" icon at top of page)

Bailey.Glen at 18:58, 3 November 2023

2023-11-03T18:58:12Z

@@ Line 1: / Line 1: @@
 {{Under Construction}}
 ==Primary Author(s)*==
@@ Line 151: / Line 156: @@
 ==Notes==
 <nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page.  If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage).  Additional global feedback or concerns are also welcome.

Bailey.Glen: Created page with "{{Under Construction}} ==Primary Author(s)*== Put your text here TOC ==Cancer Category/Type== Put your text here ==Cancer Sub-Classification / Subtype== Put your tex..."

2023-11-03T18:25:37Z

Created page with "{{Under Construction}} ==Primary Author(s)*== Put your text here __TOC__ ==Cancer Category/Type== Put your text here ==Cancer Sub-Classification / Subtype== Put your tex..."

New page

{{Under Construction}}
==Primary Author(s)*==

Put your text here

__TOC__

==Cancer Category/Type==

Put your text here

==Cancer Sub-Classification / Subtype==

Put your text here

==Definition / Description of Disease==

Put your text here

==Synonyms / Terminology==

Put your text here

==Epidemiology / Prevalence==

Put your text here

==Clinical Features==

Put your text here

==Sites of Involvement==

Put your text here

==Morphologic Features==

Put your text here

==Immunophenotype==

Put your text here and/or fill in the table

{| class="wikitable sortable"
|-
!Finding!!Marker
|-
|Positive (universal)||EXAMPLE CD1
|-
|Positive (subset)||EXAMPLE CD2
|-
|Negative (universal)||EXAMPLE CD3
|-
|Negative (subset)||EXAMPLE CD4
|}

==Chromosomal Rearrangements (Gene Fusions)==

Put your text here and/or fill in the table

{| class="wikitable sortable"
|-
!Chromosomal Rearrangement!!Genes in Fusion (5’ or 3’ Segments)!!Pathogenic Derivative!!Prevalence
|-
|EXAMPLE t(9;22)(q34;q11.2)||EXAMPLE 3'ABL1 / 5'BCR||EXAMPLE der(22)||EXAMPLE 5%
|-
|EXAMPLE t(8;21)(q22;q22)||EXAMPLE 5'RUNX1 / 3'RUNXT1||EXAMPLE der(8)||EXAMPLE 5%
|}

==Characteristic Chromosomal Aberrations / Patterns==

Put your text here

==Genomic Gain/Loss/LOH==

Put your text here and/or fill in the table

{| class="wikitable sortable"
|-
!Chromosome Number!!Gain/Loss/Amp/LOH!!Region
|-
|EXAMPLE 8||EXAMPLE Gain||EXAMPLE chr8:0-1000000
|-
|EXAMPLE 7||EXAMPLE Loss||EXAMPLE chr7:0-1000000
|}

==Gene Mutations (SNV/INDEL)==

Put your text here and/or fill in the tables

{| class="wikitable sortable"
|-
!Gene!!Mutation!!Oncogene/Tumor Suppressor/Other!!Presumed Mechanism (LOF/GOF/Other; Driver/Passenger)!!Prevalence (COSMIC/TCGA/Other)
|-
|EXAMPLE TP53||EXAMPLE R273H||EXAMPLE Tumor Suppressor||EXAMPLE LOF||EXAMPLE 20%
|}

===Other Mutations===
{| class="wikitable sortable"
|-
!Type!!Gene/Region/Other
|-
|Concomitant Mutations||EXAMPLE IDH1 R123H
|-
|Secondary Mutations||EXAMPLE Trisomy 7
|-
|Mutually Exclusive||EXAMPLE EGFR Amplification
|}

==Epigenomics (Methylation)==

Put your text here

==Genes and Main Pathways Involved==

Put your text here

==Diagnostic Testing Methods==

Put your text here

==Clinical Significance (Diagnosis, Prognosis and Therapeutic Implications)==

Put your text here

==Familial Forms==

Put your text here

==Other Information==

Put your text here

==Links==

[[Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)]]

[[Post-Transplant Lymphoproliferative Disorders]]

[[Immunodeficiency-Associated Lymphoproliferative Disorders]]

Put your links here (use "Link" icon at top of page)

==References==
(use "Cite" icon at top of page)
<references />
===EXAMPLE Book===

#Arber DA, et al., (2017). Acute myeloid leukaemia with recurrent genetic abnormalities, in World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, Revised 4th edition. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Arber DA, Hasserjian RP, Le Beau MM, Orazi A, and Siebert R, Editors. IARC Press: Lyon, France, p129-171.

==Notes==
<nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page. If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage). Additional global feedback or concerns are also welcome.

HAEM4:Monomorphic T/NK-cell PTLD - Revision history

Bailey.Glen at 21:43, 4 December 2023

Bailey.Glen at 18:58, 3 November 2023

Bailey.Glen: Created page with "{{Under Construction}} ==Primary Author(s)*== Put your text here __TOC__ ==Cancer Category/Type== Put your text here ==Cancer Sub-Classification / Subtype== Put your tex..."

Bailey.Glen: Created page with "{{Under Construction}} ==Primary Author(s)*== Put your text here TOC ==Cancer Category/Type== Put your text here ==Cancer Sub-Classification / Subtype== Put your tex..."